speaker-photo

Fadi Haddad 🇺🇸

Assistant Professor, Department of Leukemia, MD Anderson Cancer Center, Houston. Over 100 peer-reviewed publications in hematology and oncology. Significant contributions to the field of leukemia and oncology.
8:00 AM - 8:20 AM

Day 2 | Hematology Track

Precisive Approach toward Managing Ph+ ALL

8:40 AM - 9:00 AM

Day 2 | Hematology Track

Untangling the knots in Ph-like ALL

8:40 AM - 9:00 AM

Day 3 | | Hematology Track

MyeloMATCH / Clinical Paradigms in Clinical Trials

8:40 AM - 9:00 AM

Day 2 | | Hematology Track

Untangling the knots in Ph-like ALL

10:05 AM - 10:25 AM

Day 2 | | Hematology Track

DLBLC molecular subtypes, are we ready for individualized treatments?

10:25 AM - 10:45 AM

Day 2 | | Hematology Track

Updates in T-Cell lymphoma treatment

10:45 AM - 11:05 AM

Day 2 | | Hematology Track

The role of radiotherapy in lymphoma treatment, does it still have a role in the era of targeted treatments?

11:05 AM - 11:25 AM

Day 2 | | Hematology Track

Bispecific Antibodies, interesting combinations and interesting outcomes

3:20 PM - 3:40PM

Day 2 | | Hematology Track

New EHA-EMN 2025 MM guidelines: The use and positioning of new therapeutic drug classes

3:40 PM - 4:00 PM

Day 2 | | Hematology Track

How to manage high risk disease; plasma cell leukemia & extramedullary disease

4:00 PM - 4:20 PM

Day 2 | | Hematology Track

Novel approaches to newly diagnosed MM

4:20 PM - 4:40 PM

Day 2 | | Hematology Track

Defining high-risk disease in MM

5:35 PM - 5:55 PM

Day 2 | | Hematology Track

Follicular lymphoma

5:55 PM - 6:15 PM

Day 2 | | Hematology Track

Sequencing Therapy in CLL

6:15 PM - 6:35 PM

Day 2 | | Hematology Track

Nodular lymphocytes predominate Hodgkin lymphoma

6:35 PM - 6:55 PM

Day 2 | | Hematology Track

BTK targeting in lymphoma

6:55 PM - 7:15 PM

Day 2 | | Hematology Track

Updates in the management of Hodgkin lymphoma